Human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) entails the prompt administration of antiretroviral agents following potential exposure to prevent viral acquisition. Clinical ...

Mary R. Tanner, M.D., from the CDC in Atlanta, and colleagues updated the 2016 nPEP guidelines and considerations for use in the United States, including considerations for testing and nPEP regimens ...

Single-tablet therapy for HIV Researchers evaluated adherence to nonoccupational post-exposure prophylaxis following potential HIV exposure. A single-tablet regimen consisting of DOR/3TC/TDF for ...

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-U.S. (IAS-U.S.) has published new international guidelines for the treatment and prevention of ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) was associated with a substantial decline in chlamydia and syphilis incidence.

Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the case of repeat or continuing exposure after the nPEP course. HealthDay ...